Each 5 ml contains Potassium Citrate BP 1500 mg & Citric Acid Monohydrate BP 250 mg.
Potassium Citrate is absorbed and metabolized to Potassium Bicarbonate, thus acting as a systemic alkalinizer.
This combination is indicated in following cases:
Adults including the elderly and children over 6 years: 10 ml & Children under 6 years; 5 ml Urokool® Solution should be taken three times daily after meals. Urokool® solution should be taken after diluted with one glassful of water (250 ml) followed by additional water if desired.
Some products that may interact with this drug include: antacids that contain aluminium, aspirin and other salicylates, ACE inhibitors, ARBs, cardiac glycosides, potassium supplements etc.
Overdose Administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, hyperkalemia can result.
Combination of Potassium Citrate & Citric Acid Monohydrate should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus.
It is not known if this drug is found in breast milk or not. Breast-feeding women should consult with their health care.
As with all liquids containing a high concentration of potassium, patients should be directed to dilute adequately with water to minimize the possibility of gastrointestinal injury and preferably to take each dose after meals to avoid saline laxative effect. Should be used with caution when patients with low urinary output or Cardiac dysfunction is present.
Keep out of reach of children. Store in a dry place, below 25° C temperature and protected from light.